Table 2.
Gender Differences in Moxifloxacin Response
N | Female | N | Male | P | |
---|---|---|---|---|---|
QTcF Placebo baseline | 442 | 420 ± 20 | 290 | 393 ± 16 | <0.01 |
QTcF Placebo treatment | 474 | 419 ± 20 | 290 | 389 ± 17 | <0.01 |
QTcF moxifloxacin baseline | 472 | 419 ± 17 | 290 | 393 ± 17 | <0.01 |
QTcF moxifloxacin tsreatment | 474 | 434 ± 21 | 290 | 401 ± 19 | <0.01 |
Δ QTcF placebo | 442 | −1 ± 12 | 290 | −4 ± 12 | 0.01 |
ΔQTcF moxifloxacin | 472 | 16 ± 14 | 290 | 7 ± 13 | <0.01 |
ΔΔ QTcF | 440 | 17 ± 16 | 290 | 12 ± 15 | 0.04 |